Flagship explainer
What drives AYTU BIOPHARMA, INC’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$13.6M | FY2025 |
| |
| Income before tax | −$13.7M | FY2025 |
|
| Operating income | −$7.8M | FY2025 |
|
| $66.4M | FY2025 |
| |
| Ending assets | $124M | FY2025 |
|
| Beginning assets | $118M | FY2024 |
|
| $19M | FY2025 |
| |
| $27.7M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001437749-24-030062
- SEC filingFiling detailsAccession 0001437749-25-029723